|
ABOUT COMPANY
Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel platform technology. The company is headquartered in Bedford, Massachusetts.
|
EARNINGS
Gross Profit (TTM): -13374000
Market Capitalization: 563085000
Operating Margin (TTM): -1.927
PE Ratio: None
PEG Ratio: 0
Profit Margin: -2.29
Revenue Per Share (TTM): 0.515
Revenue (TTM): 38563000
Quarterly Earnings Growth YOY: 0
Quarterly Revenue Growth YOY: 1.068
Trailing PE: -
|
DIVIDENDS
Diluted EPS (TTM): -1.965
Dividend Date: None
Dividend Per Share: None
Dividend Yield: 0%
EBITDA: -71014000
ExDividend Date: None
Forward Annual Dividend Rate:
Forward Annual Dividend Yield:
|